Miami, Florida, United States, Octoberber 2025 – eMed Population Health, Inc. has announced the appointment of Dr. Dyan Hes as Chief Medical Officer. A board-certified pediatrician and Diplomate of the American Board of Obesity Medicine (ABOM), Dr. Hes will provide executive medical leadership with a focus on advancing preemptive care management and improving outcomes at scale.
In her new role, Dr. Hes will advise eMed’s clinical, product, and technology teams on evidence-based care models, while optimizing GLP-1 therapies for diverse patient populations. She will also play a pivotal role in strengthening partnerships with business leaders and investors, demonstrating the potential to reduce medical care costs for employers and insurers.
“Through the addition of Dr. Dyan Hes to the eMed leadership team, we are excited to continue our path as a leader in transforming population health,” said Linda Yaccarino, CEO of eMed Population Health. “Her award-winning work and background in obesity medicine will further eMed’s evolution of what employee health benefits and public health programs can look like.”
With over 25 years of experience in obesity medicine and pediatrics, Dr. Hes’ expertise will shape eMed’s approach to improving adherence, retention, and clinical outcomes while managing costs. A recognized leader in the use of GLP-1 agonists and innovative weight loss treatments, she is also the founder and medical director of Highline Modern Medicine, a concierge practice serving patients in New York City, the Hamptons, and South Florida. Previously, she founded and led Gramercy Pediatrics, LLC in New York City and served as a Director of the ABOM for eight years.
Commenting on her appointment, Dr. Hes said, “We are at a pivotal moment in preemptive care management. eMed’s transformational approach is at the forefront of driving what’s possible for public health and medicine. We’re working to shape a healthier future for all we serve.”
Dr. Hes is also a frequent medical correspondent, contributing to outlets including CBS, Fox News, and NewsNation, further extending her influence as a thought leader in modern healthcare.
About eMed
eMed is the world’s first end-to-end GLP-1 care platform built on Empathetic AI™. Its integrated, digital-first approach unites at-home diagnostics, proctor-led screenings, clinician-directed prescribing, and adherence coaching to establish a new global standard for population health. With expanding provider networks, data intelligence, and behavioral health capabilities, eMed partners with employers and payers to deliver measurable outcomes, accountability, and compassion in employee health benefits and public health programs.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
